Methazolamide
| Names | |
|---|---|
| Other names | N-(3-Methyl-5-sulfamoyl-3H-1,3,4-thiadiazol-2-ylidene) ethanamide |
| |
| Clinical data | |
| Drug class | Carbonic anhydrase inhibitor[1] |
| Main uses | Glaucoma[1] |
| Side effects | Numbness, hearing problems, tiredness, nausea, diarrhea, sleepiness[1] |
| Pregnancy category |
|
| Routes of use | By mouth |
| Onset of action | Within 4 hrs[1] |
| Duration of action | Up to 18 hrs[1] |
| External links | |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a601233 |
| Legal | |
| Legal status |
|
| Pharmacokinetics | |
| Protein binding | ~55% |
| Elimination half-life | ~14 hours |
| Chemical and physical data | |
| Formula | C5H8N4O3S2 |
| Molar mass | 236.26 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Methazolamide, sold under the brand name Neptazane among, is a medication used to treat increased intraocular pressure (IOP) including in glaucoma.[1] It is taken by mouth.[1] Effects begin within 4 hours and last for up to 18 hours.[1]
Common side effects include numbness, hearing problems, tiredness, nausea, diarrhea, and sleepiness.[1] Other side effects may include Stevens-Johnson syndrome.[1] It is an carbonic anhydrase inhibitor which decreases the production of aqueous humor.[1]
Methazolamide was approved for medical use in the United States in 1950s.[1][2] In the United States 60 tablets of 50 mg costs about 125 USD as of 2021.[3]
Medical uses
It is used for open angle glaucoma and secondary glaucoma.[1] Also it is used preoperatively in acute angle-closure (narrow-angle) glaucoma where lowering the IOP is desired before surgery.[1]
Dosage
The typical dose is 50 to 100 mg two or three times per day.[1]
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 "Methazolamide Monograph for Professionals". Drugs.com. Archived from the original on 7 May 2021. Retrieved 17 November 2021. Archived 7 May 2021 at the Wayback Machine
- ↑ Supuran, Claudiu T.; Nocentini, Alessio (17 July 2019). Carbonic Anhydrases: Biochemistry and Pharmacology of an Evergreen Pharmaceutical Target. Academic Press. p. 271. ISBN 978-0-12-816745-8. Archived from the original on 17 November 2021. Retrieved 17 November 2021. Archived 17 November 2021 at the Wayback Machine
- ↑ "Methazolamide Prices, Coupons & Savings Tips - GoodRx". GoodRx. Archived from the original on 5 November 2016. Retrieved 17 November 2021. Archived 5 November 2016 at the Wayback Machine
External links
| Identifiers: |
|
|---|
- Pages using duplicate arguments in template calls
- Pages using the JsonConfig extension
- Webarchive template wayback links
- Chemical articles with unknown parameter in Infobox drug
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs missing an ATC code
- Drugboxes which contain changes to verified fields
- Articles with changed KEGG identifier
- Articles with changed EBI identifier
- Acetamides
- Carbonic anhydrase inhibitors
- Sulfonamides
- Thiadiazoles
- RTT
- All stub articles
- Antihypertensive agent stubs